CK18, as a prognostic biomarker, is involved in both cell motility and cancer progression; the positive expression of CK18 is considered suggestive of oncofoetal transformation, malignant transformation, or initiation of abnormal cell differentiation50,51. Here, KRT18 is linked to cancer.